Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients.
Ely S, Forsberg P, Ouansafi I, Rossi A, Modin A, Pearse R, Pekle K, Perry A, Coleman M, Jayabalan D, Di Liberto M, Chen-Kiang S, Niesvizky R, Mark TM.
Ely S, et al. Among authors: modin a.
Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):825-833. doi: 10.1016/j.clml.2017.09.010. Epub 2017 Sep 20.
Clin Lymphoma Myeloma Leuk. 2017.
PMID: 29051077